A Narrative Review of <sup>99m</sup>Tc-Aprotinin in the Diagnosis of Cardiac Amyloidosis and a New Life for an Unfairly Abandoned Drug

Several studies investigated the use of <sup>99m</sup>Tc-labelled Aprotinin as an amyloid seeker some years ago. In vitro tests showed high binding affinity for several types of amyloid fibrils accompanied by an excellent specificity. Initial human studies demonstrated good accuracy in d...

Full description

Bibliographic Details
Main Authors: Carlo Aprile, Lorenzo Lodola
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/6/1377
_version_ 1797489698287910912
author Carlo Aprile
Lorenzo Lodola
author_facet Carlo Aprile
Lorenzo Lodola
author_sort Carlo Aprile
collection DOAJ
description Several studies investigated the use of <sup>99m</sup>Tc-labelled Aprotinin as an amyloid seeker some years ago. In vitro tests showed high binding affinity for several types of amyloid fibrils accompanied by an excellent specificity. Initial human studies demonstrated good accuracy in detecting cardiac involvement. Scintigraphy results were confirmed in a group of 28 endomyocardial biopsies. Unfortunately, clinical studies were halted because of a temporary suspension of the vector protein (Trasylol) and public health concerns over prion contamination of the bovine origin compound. To obviate these limitations, efforts have been made to label a recombinant Aprotinin with 99mTc, which exhibits the same affinity for h-insulin fibrils. With the aim of developing a PET tracer, the same recombinant protein was labeled with Gallium. The introduction of a bifunctional chelator did not affect fibril affinity. Finally, a synthetic peptidic fragment, the cyclic 30-51 SS, was synthetized. After direct technetium labeling, an impressive increase in affinity was demonstrated. This peptide appears to be a potential candidate for Gallium labeling through a bifunctional chelator for PET imaging.
first_indexed 2024-03-10T00:21:20Z
format Article
id doaj.art-ecdc6c787b59434096d8799b6a87167d
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T00:21:20Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-ecdc6c787b59434096d8799b6a87167d2023-11-23T15:43:47ZengMDPI AGBiomedicines2227-90592022-06-01106137710.3390/biomedicines10061377A Narrative Review of <sup>99m</sup>Tc-Aprotinin in the Diagnosis of Cardiac Amyloidosis and a New Life for an Unfairly Abandoned DrugCarlo Aprile0Lorenzo Lodola1IRCCS Fondazione Policlinico San Matteo, Nuclear Medicine Unit, I-27100 Pavia, ItalyIRCCS Fondazione Policlinico San Matteo, Nuclear Medicine Unit, I-27100 Pavia, ItalySeveral studies investigated the use of <sup>99m</sup>Tc-labelled Aprotinin as an amyloid seeker some years ago. In vitro tests showed high binding affinity for several types of amyloid fibrils accompanied by an excellent specificity. Initial human studies demonstrated good accuracy in detecting cardiac involvement. Scintigraphy results were confirmed in a group of 28 endomyocardial biopsies. Unfortunately, clinical studies were halted because of a temporary suspension of the vector protein (Trasylol) and public health concerns over prion contamination of the bovine origin compound. To obviate these limitations, efforts have been made to label a recombinant Aprotinin with 99mTc, which exhibits the same affinity for h-insulin fibrils. With the aim of developing a PET tracer, the same recombinant protein was labeled with Gallium. The introduction of a bifunctional chelator did not affect fibril affinity. Finally, a synthetic peptidic fragment, the cyclic 30-51 SS, was synthetized. After direct technetium labeling, an impressive increase in affinity was demonstrated. This peptide appears to be a potential candidate for Gallium labeling through a bifunctional chelator for PET imaging.https://www.mdpi.com/2227-9059/10/6/1377cardiac amyloidosistechnetium aprotininrecombinant aprotinin30-51 SS cyclic peptide: synthetic insulin fibrilsradioactive GalliumPET
spellingShingle Carlo Aprile
Lorenzo Lodola
A Narrative Review of <sup>99m</sup>Tc-Aprotinin in the Diagnosis of Cardiac Amyloidosis and a New Life for an Unfairly Abandoned Drug
Biomedicines
cardiac amyloidosis
technetium aprotinin
recombinant aprotinin
30-51 SS cyclic peptide: synthetic insulin fibrils
radioactive Gallium
PET
title A Narrative Review of <sup>99m</sup>Tc-Aprotinin in the Diagnosis of Cardiac Amyloidosis and a New Life for an Unfairly Abandoned Drug
title_full A Narrative Review of <sup>99m</sup>Tc-Aprotinin in the Diagnosis of Cardiac Amyloidosis and a New Life for an Unfairly Abandoned Drug
title_fullStr A Narrative Review of <sup>99m</sup>Tc-Aprotinin in the Diagnosis of Cardiac Amyloidosis and a New Life for an Unfairly Abandoned Drug
title_full_unstemmed A Narrative Review of <sup>99m</sup>Tc-Aprotinin in the Diagnosis of Cardiac Amyloidosis and a New Life for an Unfairly Abandoned Drug
title_short A Narrative Review of <sup>99m</sup>Tc-Aprotinin in the Diagnosis of Cardiac Amyloidosis and a New Life for an Unfairly Abandoned Drug
title_sort narrative review of sup 99m sup tc aprotinin in the diagnosis of cardiac amyloidosis and a new life for an unfairly abandoned drug
topic cardiac amyloidosis
technetium aprotinin
recombinant aprotinin
30-51 SS cyclic peptide: synthetic insulin fibrils
radioactive Gallium
PET
url https://www.mdpi.com/2227-9059/10/6/1377
work_keys_str_mv AT carloaprile anarrativereviewofsup99msuptcaprotinininthediagnosisofcardiacamyloidosisandanewlifeforanunfairlyabandoneddrug
AT lorenzolodola anarrativereviewofsup99msuptcaprotinininthediagnosisofcardiacamyloidosisandanewlifeforanunfairlyabandoneddrug
AT carloaprile narrativereviewofsup99msuptcaprotinininthediagnosisofcardiacamyloidosisandanewlifeforanunfairlyabandoneddrug
AT lorenzolodola narrativereviewofsup99msuptcaprotinininthediagnosisofcardiacamyloidosisandanewlifeforanunfairlyabandoneddrug